Table 7 Summary of urodynamic measurements by visit and treatment

Visit

Intervention

(VISPO)

n = 33

Comparator

(SPO)

n = 33

Placebo

n = 33

p-value**

Intervention

(VISPO)

n = 33

p-value*

Comparator

(SPO)

n = 33

p-value*

Placebo

n = 33

p-value*

p-value**

Visit 1

112.55 ± 36.19

110.12 ± 34.71

114.17 ± 30.67

0.888⁽¹⁾

−12.76 ± 14.44^a

< 0.001

−1.88 ± 10.93^b

0.331

1.11 ± 13.89^b

0.649

< 0.001⁽¹⁾

Visit 3

99.79 ± 29.27

108.24 ± 33.22

115.28 ± 33.25

0.149⁽¹⁾

Visit

Intervention

(VISPO)

n = 33

Comparator

(SPO)

n = 33

Placebo

n = 33

p-value**

Intervention

(VISPO)

n = 33

p-value*

Comparator

(SPO)

n = 33

p-value*

Placebo

n = 33

p-value*

p-value**

Visit 1

11.85 ± 2.06

12.33 ± 1.61

12.27 ± 1.92

0.522⁽¹⁾

2.42 ± 2.61^a

< 0.001

0.48 ± 1.56^b

0.084

−0.64 ± 2.28^b

0.118

< 0.001⁽¹⁾

Visit 3

14.27 ± 2.54^a

12.82 ± 1.72^b

11.64 ± 1.41^c

< 0.001⁽²⁾